Discovery of ruthenium(ii) metallocompound and olaparib synergy for cancer combination therapy
Synergistic drug combinations can extend the use of poly(ADP-ribose) polymerase inhibitors (PARPi) such as Olaparib to BRCA-proficient tumors and overcome acquired or de novo drug resistance. To identify new synergistic combinations for PARPi, we screened a “micro-library” comprising a mix of commer...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Article |
| 语言: | English |
| 出版: |
American Chemical Society
2023
|
| 在线阅读: | http://psasir.upm.edu.my/id/eprint/107358/1/107358.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|